Boston Scientific U.S. — Long-Lived Assets increased by 1.5% to $1.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.0%, from $1.52B to $1.95B.
bsx_segment_u_s_long_lived_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $1.19B | $1.24B | $1.30B | $1.46B | $1.52B | $1.53B | $1.81B | $1.92B | $1.95B |
| QoQ Change | — | +4.3% | +4.8% | +12.4% | +4.2% | +0.5% | +18.4% | +5.9% | +1.5% |
| YoY Change | — | +4.3% | +4.8% | +12.4% | — | — | — | +31.3% | +28.0% |